Semaglutide and cardiovascular outcomes by baseline HbA1c in diabetes: the SUSTAIN 6 and PIONEER 6 trials
European Heart Journal
28 February 2024
Organised by: 

Contributors

Linda G Mellbin
Author

Deepak L Bhatt
Author
Icahn School of Medicine at Mount Sinai New York City , United States of America

Jens-Peter David
Author

Kathrine Ekström
Author

Mark C Petrie
Author

Søren Rasmussen
Author

Tina Vilsbøll
Author
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation

